Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
Results from the UK Biobank study, one of the largest cohorts of middle-aged adults to provide data for HbA1c across the glycemic spectrum as well as measures of cognitive function, neuroimaging, and dementia, were recently published in the journal Diabetes, Obesity & Metabolism. The authors report that both prediabetes and diabetes were associated with an increase in risk for vascular dementia and cognitive decline, while diabetes was also associated with an increase in risk for all-cause and Alzheimer’s dementias. This study adds to the growing body of research pointing to diabetes as only one part of a spectrum rather than a distinct disease, as well as the importance of addressing any impairments in glucose regulation as early as possible.
The nearly 500,000 participants in this study were categorized in one of the following five groups: low HbA1c (mean 5.1), normoglycemic (mean 5.6), prediabetes (mean 6.2), known diabetes (mean 7.0), or unknown diabetes (mean 7.5). Prediabetes was associated with a 54% increased (adjusted) risk for vascular dementia, while diabetes carried a nearly 3-fold higher risk. Prediabetes and diabetes had a similar increase in risk for cognitive decline (42% and 39%, respectively), while diabetes had a nearly 2-fold higher risk for both all-cause and Alzheimer’s dementias.
Antihypertensive medication use appeared to account for some of the excess risk found between prediabetes and vascular dementia. The authors suggest rather than an adverse effect of medication, this is more likely an indicator of hypertension that had been untreated for far too long, again emphasizing the importance of optimizing both blood pressure and glucose/insulin regulation early, rather than waiting for overt disease to progress.
There also was an apparent benefit in the low HbA1c group; individuals in this group had greater hippocampal volume and lower white matter hyperintensity (WMH) volume compared with normoglycemic individuals. Hippocampal atrophy is a consequence of hyperglycemia linked to cognitive decline and memory loss, while WMH volume is a tentative indicator of neurological decline. In sharp contrast, hippocampal volume declined approximately 80mm3 among diabetics compared to those with normoglycemia, in contrast to the 12mm3 increase found among those in the low HbA1c group. Given the nearly 2-fold increase in cardiovascular disease risk among prediabetics (in a separate analysis of this same cohort), the advantage to achieving healthy glucose control could not be clearer.
Submit this form and you'll receive our latest news and updates.
Results of a randomized controlled trial performed to evaluate the effectiveness of a prebiotic supplement on both muscl...
Learn moreResults of a cross-sectional study were recently published in the Journal of Translational Medicine, detailing the assoc...
Learn moreThe Lancet has just published the results of the first randomized and controlled trial evaluating the effect of hearing ...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment